Emtricitabine/Tenofovir for post-exposure prophylaxis against HIV a review of clinical effectiveness and cost-effectiveness
The objective of this Rapid Response report is to evaluate the clinical and cost-effectiveness of TDF plus FTC, with or without integrase strand transfer inhibitors, as compared with other NRTI regimens with or without protease inhibitors boosted with ritonavir
Main Authors: | , |
---|---|
Corporate Author: | |
Format: | eBook |
Language: | English |
Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2017, March 17, 2017
|
Edition: | Version 1.0 |
Series: | CADTH rapid response report: summary with critical appraisal
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | The objective of this Rapid Response report is to evaluate the clinical and cost-effectiveness of TDF plus FTC, with or without integrase strand transfer inhibitors, as compared with other NRTI regimens with or without protease inhibitors boosted with ritonavir |
---|---|
Physical Description: | 1 PDF file (22 pages) illustration |